China grants conditional approval for Pfizer’s COVID-19 drug Paxlovid

(G.N.S) Dt. 12 Beijing China’s medical products regulator has granted conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the nation. The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate